Free Trial

Fulcrum Therapeutics (FULC) Institutional Ownership

Fulcrum Therapeutics logo
$7.10 -0.15 (-2.01%)
Closing price 03:59 PM Eastern
Extended Trading
$7.10 -0.01 (-0.13%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Fulcrum Therapeutics (NASDAQ:FULC)

Current
Institutional Ownership
Percentage
89.83%
Number of
Institutional Buyers
(last 12 months)
99
Total
Institutional Inflows
(last 12 months)
$235.65M
Number of
Institutional Sellers
(last 12 months)
51
Total
Institutional Outflows
(last 12 months)
$109.48M
Get FULC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fulcrum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

FULC Institutional Buying and Selling by Quarter

Fulcrum Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Siren L.L.C.2,350,000$18.02M0.5%+20.5%3.527%
5/7/2026 Dimensional Fund Advisors LP1,130,281$8.66M0.0%+7.5%1.696%
5/5/2026 Bank of New York Mellon Corp149,942$1.15M0.0%+28.3%0.225%
4/30/2026 Hsbc Holdings PLC58,636$442K0.0%+35.5%0.088%
4/30/2026 Summit Securities Group LLC6,975$53K0.0%N/A0.010%
4/27/2026 Simplify Asset Management Inc.115,994$890K0.0%-27.4%0.174%
4/27/2026 Y Intercept Hong Kong Ltd153,344$1.18M0.0%+129.8%0.230%
4/20/2026 Assenagon Asset Management S.A.1,193,873$9.16M0.0%N/A1.793%
3/20/2026 Hsbc Holdings PLC43,262$498K0.0%-19.6%0.065%
2/19/2026 Invesco Ltd.417,189$4.72M0.0%+236.8%0.771%
2/18/2026XTX Topco Ltd51,802$586K0.0%N/A0.096%
2/18/2026Ikarian Capital LLC1,375,472$15.56M1.2%+6.7%2.542%
2/18/2026Vestal Point Capital LP950,000$10.74M0.4%N/A1.755%
2/18/2026Virtus Investment Advisers LLC20,463$231K0.1%N/A0.038%
2/18/2026Wellington Management Group LLP146,427$1.66M0.0%-18.4%0.271%
2/18/2026SummitTX Capital L.P.138,143$1.56M0.0%N/A0.255%
2/18/2026Superstring Capital Management LP72,060$815K0.4%N/A0.133%
2/18/2026Suvretta Capital Management LLC6,561,111$74.21M1.5%+21.9%12.124%
2/18/2026Millennium Management LLC54,431$616K0.0%-63.9%0.101%
2/18/2026Man Group plc15,253$173K0.0%N/A0.028%
2/18/2026Catalio Capital Management LP201,301$2.28M0.4%N/A0.372%
2/18/2026Balyasny Asset Management L.P.970,439$10.98M0.0%-33.1%1.793%
2/18/2026Boothbay Fund Management LLC517,526$5.85M0.1%-23.7%0.956%
2/17/2026Schonfeld Strategic Advisors LLC16,791$190K0.0%-95.4%0.031%
2/17/2026Burkehill Global Management LP50,000$566K0.0%N/A0.092%
2/17/2026AQR Capital Management LLC15,502$175K0.0%N/A0.029%
2/17/2026Braidwell LP3,061,222$34.62M1.1%+1,294.7%5.656%
2/17/2026Jain Global LLC41,260$467K0.0%N/A0.076%
2/17/2026RA Capital Management L.P.6,053,960$68.47M0.7%-40.8%11.186%
2/17/2026Trexquant Investment LP355,547$4.02M0.0%+1,591.9%0.657%
2/17/2026Jump Financial LLC92,200$1.04M0.0%N/A0.170%
2/17/2026Price T Rowe Associates Inc. MD63,760$722K0.0%-3.2%0.118%
2/17/2026Adage Capital Partners GP L.L.C.1,700,000$19.23M0.0%-30.1%3.141%
2/17/2026 Russell Investments Group Ltd.3,574$40K0.0%-74.0%0.007%
2/17/2026Atom Investors LP60,595$685K0.1%N/A0.112%
2/17/2026State of Wisconsin Investment Board86,499$978K0.0%+533.0%0.160%
2/17/2026Royal Bank of Canada4,107$47K0.0%-99.6%0.008%
2/17/2026Graham Capital Management L.P.48,464$548K0.0%+59.0%0.090%
2/17/2026 Persistent Asset Partners Ltd6,615$75K0.0%N/A0.012%
2/16/2026Squarepoint Ops LLC65,852$745K0.0%+269.4%0.122%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
2/16/2026Verition Fund Management LLC74,691$845K0.0%N/A0.138%
2/16/2026Maven Securities LTD100,000$1.13M0.0%N/A0.185%
2/16/2026Nicholas Investment Partners LP182,961$2.07M0.2%N/A0.338%
2/16/2026First Turn Management LLC1,892,683$21.41M2.4%N/A3.497%
2/16/2026Entropy Technologies LP11,996$136K0.0%N/A0.022%
2/16/2026Barclays PLC132,541$1.50M0.0%+47.9%0.245%
2/13/2026Nantahala Capital Management LLC4,293,346$48.56M1.6%-8.1%7.933%
2/13/2026Marshall Wace LLP102,921$1.16M0.0%N/A0.190%
2/13/2026The Manufacturers Life Insurance Company 12,883$146K0.0%-7.6%0.024%
2/13/2026 Walleye Capital LLC108,434$1.23M0.0%N/A0.200%
2/13/2026Quarry LP17,165$194K0.0%+354.8%0.032%
2/13/2026Exome Asset Management LLC92,055$1.04M0.5%-6.8%0.170%
2/13/2026Siren L.L.C.1,950,000$22.05M0.7%N/A3.603%
2/13/2026Charles Schwab Investment Management Inc.388,896$4.40M0.0%+16.6%0.719%
2/13/2026State Street Corp1,005,345$11.37M0.0%-5.4%1.858%
2/13/2026 Wells Fargo & Company MN166,395$1.88M0.0%+411.9%0.307%
2/12/2026MetLife Investment Management LLC22,714$257K0.0%-12.3%0.042%
2/12/2026GSK plc1,785,714$20.20M2.5%N/A3.300%
2/12/2026 Commonwealth Equity Services LLC40,000$452K0.0%-52.1%0.074%
2/12/2026Renaissance Technologies LLC17,400$197K0.0%-93.0%0.032%
2/12/2026 Dimensional Fund Advisors LP1,051,124$11.89M0.0%-19.1%1.942%
2/12/2026EntryPoint Capital LLC15,076$171K0.1%N/A0.028%
2/12/2026Integrated Quantitative Investments LLC62,522$707K0.2%N/A0.116%
2/12/2026Informed Momentum Co LLC61,620$697K0.1%N/A0.114%
2/12/2026 New York State Common Retirement Fund57,725$653K0.0%+340.6%0.107%
2/12/2026Campbell & CO Investment Adviser LLC35,601$403K0.0%-65.3%0.066%
2/11/2026 Meeder Asset Management Inc.3,479$39K0.0%N/A0.006%
2/11/2026 Deutsche Bank AG287,096$3.25M0.0%+0.6%0.530%
2/11/2026 Fox Run Management L.L.C.25,568$289K0.0%-49.7%0.047%
2/11/2026Franklin Resources Inc.44,249$500K0.0%-26.3%0.082%
2/11/2026 WINTON GROUP Ltd14,294$162K0.0%-11.8%0.026%
2/10/2026Goldman Sachs Group Inc.323,879$3.66M0.0%-44.8%0.598%
2/10/2026AXQ Capital LP31,545$357K0.1%N/A0.058%
2/10/2026 Intech Investment Management LLC19,747$223K0.0%+14.5%0.036%
2/10/2026 Seven Grand Managers LLC50,000$566K0.0%N/A0.092%
2/9/2026Geode Capital Management LLC1,105,813$12.51M0.0%+10.1%2.043%
2/9/2026 Simplify Asset Management Inc.159,674$1.81M0.0%+91.8%0.295%
2/6/2026Legato Capital Management LLC66,347$750K0.1%N/A0.123%
2/6/2026 GSA Capital Partners LLP99,709$1.13M0.1%-14.1%0.184%
2/6/2026 ProShare Advisors LLC10,259$116K0.0%N/A0.019%
2/4/2026 Bailard Inc.11,781$133K0.0%-56.2%0.022%
2/2/2026 Strs Ohio49,300$558K0.0%-36.7%0.091%
1/29/2026 Matisse Capital13,460$152K0.1%-27.8%0.025%
1/29/2026 China Universal Asset Management Co. Ltd.8,819$100K0.0%N/A0.016%
1/26/2026 Mirae Asset Global Investments Co. Ltd.2,630$30K0.0%N/A0.005%
1/23/2026 Farther Finance Advisors LLC2,190$25K0.0%-69.2%0.004%
1/23/2026 Assetmark Inc.8,184$93K0.0%-14.8%0.015%
1/16/2026 Aberdeen Group plc1,254,027$14.18M0.0%+809.0%2.317%
1/9/2026 SG Americas Securities LLC11,766$133K0.0%N/A0.022%
1/1/2026JPMorgan Chase & Co.18,069$166K0.0%-30.9%0.033%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
11/17/2025Jacobs Levy Equity Management Inc.70,015$644K0.0%-24.3%0.129%
11/17/2025 PharVision Advisers LLC23,868$220K0.1%N/A0.044%
11/17/2025Quarry LP3,774$35K0.0%N/A0.007%
11/17/2025Prelude Capital Management LLC28,832$265K0.0%-79.9%0.053%
11/17/2025Nantahala Capital Management LLC4,670,784$42.97M1.5%+8.9%8.630%
11/17/2025Millennium Management LLC150,867$1.39M0.0%+42.7%0.279%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,006$184K0.0%-32.0%0.037%
11/17/2025Brevan Howard Capital Management LP15,303$141K0.0%N/A0.028%
11/17/2025Bank of America Corp DE147,211$1.35M0.0%+220.1%0.272%
11/17/2025Boothbay Fund Management LLC678,414$6.24M0.1%+104.2%1.254%


FULC Institutional Ownership - Frequently Asked Questions

During the previous two years, 150 institutional investors and hedge funds held shares of Fulcrum Therapeutics. The most heavily invested institutionals were Suvretta Capital Management LLC ($74.21M), RA Capital Management L.P. ($68.47M), Nantahala Capital Management LLC ($48.56M), Braidwell LP ($34.62M), Vanguard Group Inc. ($27.60M), Siren L.L.C. ($22.05M), and First Turn Management LLC ($21.41M).Learn more on Fulcrum Therapeutics' institutional investors.

89.83% of Fulcrum Therapeutics' stock is owned by institutional investors. Learn more on FULC's institutional investor holdings.

Of the 125 institutional investors that purchased Fulcrum Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($4.13M), Suvretta Capital Management LLC ($3.63M), Adage Capital Partners GP L.L.C. ($2.59M), Siren L.L.C. ($1.95M), First Turn Management LLC ($1.89M), GSK plc ($1.79M), and Assenagon Asset Management S.A. ($1.69M).

Institutional investors have bought a total of 24,115,764 shares in the last 24 months. This purchase volume represents approximately $232.58M in transactions.

Of the 50 institutional investors that sold Fulcrum Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($4.18M), Royal Bank of Canada ($996.74K), Nantahala Capital Management LLC ($911.83K), Adage Capital Partners GP L.L.C. ($732K), Goldman Sachs Group Inc. ($541.79K), Woodline Partners LP ($512.90K), and Balyasny Asset Management L.P. ($480.04K).

Institutional investors have sold a total of 10,790,173 shares in the last 24 months. This volume of shares sold represents approximately $109.48M in transactions.



This page (NASDAQ:FULC) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners